Immunovant Inc (NASDAQ: IMVT) established initial surge of 5.31% at $24.81, as the Stock market unbolted on Thursday, before settling in for the price of $23.56 at the close. Taking a more long-term approach, IMVT posted a 52-week range of $12.72-$29.23.
The Healthcare sector firm’s twelve-monthly sales growth has been -12.18% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -12.18%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -6.32%. This publicly-traded company’s shares outstanding now amounts to $174.53 million, simultaneously with a float of $74.15 million. The organization now has a market capitalization sitting at $4.35 billion. At the time of writing, stock’s 50-day Moving Average stood at $21.36, while the 200-day Moving Average is $17.50.
Immunovant Inc (IMVT) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Immunovant Inc industry. Immunovant Inc’s current insider ownership accounts for 57.69%, in contrast to 54.83% institutional ownership. According to the most recent insider trade that took place on Dec 01 ’25, this organization’s Director sold 22,249 shares at the rate of 23.25, making the entire transaction reach 517,189 in total value, affecting insider ownership by 85,852. Preceding that transaction, on Dec 01 ’25, Company’s Director sold 15,000 for 23.24, making the whole transaction’s value amount to 348,665. This particular insider is now the holder of 120,773 in total.
Immunovant Inc (IMVT) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
Immunovant Inc’s EPS decrease for this current 12-month fiscal period is -6.32% and is forecasted to reach -3.03 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -0.35% through the next 5 years, which can be compared against the -12.18% growth it accomplished over the previous five years trading on the market.
Immunovant Inc (NASDAQ: IMVT) Trading Performance Indicators
Let’s observe the current performance indicators for Immunovant Inc (IMVT). It’s Quick Ratio in the last reported quarter now stands at 9.07.
In the same vein, IMVT’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.83, a figure that is expected to reach -0.72 in the next quarter, and analysts are predicting that it will be -3.03 at the market close of one year from today.
Technical Analysis of Immunovant Inc (IMVT)
Now, what If we examine the latest scores posted by [Immunovant Inc, IMVT]. During the last 5-days, its volume was better the volume of 1.55 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 51.65% While, its Average True Range was 66.38.
Raw Stochastic average of Immunovant Inc (IMVT) in the period of the previous 100 days is set at 82.34%, which indicates a major rise in contrast to 56.73% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.16 that was higher than 0.97 volatility it exhibited in the past 100-days period.
